Progyny (NASDAQ:PGNY): An Affordable Growth Play With Double-Digit Earnings Expansion
Progyny Inc PGNY
$31.13
โผ -1.14%
($-0.36)
📅 Earnings This Week
Open
$31.40
Prev Close
$31.49
Day Range
$31.02 โ $31.84
52W Range
$16.10 โ $33.07
Market Cap
$2.44B
P/E (TTM)
36.02
Beta
1.02
EPS (TTM)
$0.77
๐ Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-10-25 |
| Shares Out. | 78,330,000 |
| Website | progyny.com/ โ |
| Phone | 18009279800 |
| Employees | 856 |
| Revenue | $328.5M |
| Gross Profit | $83.1M |
| Net Income | $24.2M |
| Free Cash Flow | $184.4M |
| Total Assets | $698.3M |
| Total Liabilities | $259.0M |
| Equity | $439.3M |
About Progyny Inc
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Progyny Inc is a publicly traded company under the ticker symbol PGNY on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
17 analysts (2026-07-01)
๐ฐ Latest News for PGNY
This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Barclays Downgrades Progyny to Equal-Weight, Raises Price Target to $34
Progyny (PGNY): Strong Growth with Technical Setup Quality
BTIG Maintains Buy on Progyny, Raises Price Target to $40
Canaccord Genuity Maintains Buy on Progyny, Raises Price Target to $36

